chr7-6003717-T-TC
Variant summary
Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PVS1PS3PM2PP5_Very_Strong
The NM_000535.7(PMS2):c.325dupG(p.Glu109GlyfsTer30) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 151,980 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000625635: Studies have shown that this premature translational stop signal alters mRNA splicing and is expected to lead to the loss of protein expression (PMID:26247049).". Synonymous variant affecting the same amino acid position (i.e. E109E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay. The gene PMS2 is included in the ClinGen Criteria Specification Registry.
Frequency
Consequence
NM_000535.7 frameshift
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Lynch syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- mismatch repair cancer syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- ovarian cancerInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 22 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000535.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | MANE Select | c.325dupG | p.Glu109GlyfsTer30 | frameshift | Exon 4 of 15 | NP_000526.2 | P54278-1 | ||
| PMS2 | c.511dupG | p.Glu171GlyfsTer30 | frameshift | Exon 5 of 16 | NP_001393795.1 | A0A8V8TNX6 | |||
| PMS2 | c.325dupG | p.Glu109GlyfsTer30 | frameshift | Exon 4 of 15 | NP_001308943.1 | A0A8V8TQ50 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PMS2 | TSL:1 MANE Select | c.325dupG | p.Glu109GlyfsTer30 | frameshift | Exon 4 of 15 | ENSP00000265849.7 | P54278-1 | ||
| PMS2 | TSL:1 | c.325dupG | p.Glu109GlyfsTer30 | frameshift | Exon 4 of 11 | ENSP00000371758.4 | P54278-2 | ||
| PMS2 | TSL:1 | n.325dupG | non_coding_transcript_exon | Exon 4 of 13 | ENSP00000514464.1 | P54278-3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151980Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000169 AC: 4AN: 236098 AF XY: 0.0000231 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000485 AC: 7AN: 1443120Hom.: 0 Cov.: 29 AF XY: 0.00000557 AC XY: 4AN XY: 718708 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151980Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74224 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at